Control of Frequentist type I error rates in hierarchical linear models for multiregional clinical trials using a Bayesian method

被引:0
|
作者
Kim, Jeewuan [1 ,2 ]
Kang, Seung-Ho [1 ,2 ]
Jin, Ick Hoon [1 ,2 ]
Park, Junhui [1 ,3 ]
机构
[1] Yonsei Univ, Dept Stat & Data Sci, Seoul, South Korea
[2] Yonsei Univ, Dept Appl Stat, Seoul, South Korea
[3] Pukyong Natl Univ, Human Bioconvergence, Busan, South Korea
基金
新加坡国家研究基金会;
关键词
Bayesian credible levels; Generalized linear mixed models; Multiregional strategy; SAMPLE-SIZE; CONSISTENCY ASSESSMENT; VARIANCE PARAMETERS; PRIOR DISTRIBUTIONS; DESIGN; REGIONS; GUIDELINES;
D O I
10.1080/03610918.2024.2371003
中图分类号
O21 [概率论与数理统计]; C8 [统计学];
学科分类号
020208 ; 070103 ; 0714 ;
摘要
A multiregional clinical trial is a clinical trial conducted simultaneously in multiple regions under a single protocol. It is a new drug development strategy that has advantages in many ways. A significant part of these advantages comes from the hierarchical data structure of the multiregional clinical trials. Based on the recent work of Kim and Kang (2020) concerning hierarchical linear models to better reflect the structure, we address the problem of controlling the Frequentist type I error rate when the number of regions is small using a Bayesian method. More precisely, we present a strategy for controlling the type I error rate by setting a prespecified Bayesian credible level. Simulation results show that our proposed method controls the type I error rate reliably and well. Through sensitivity analysis, we also investigate the effect on the results when accurate information on between-region variability is given and when several different types of prior distributions are used.
引用
收藏
页数:21
相关论文
共 26 条
  • [1] Hierarchical Linear Models for Multiregional Clinical Trials
    Kim, Saemina
    Kang, Seung-Ho
    [J]. STATISTICS IN BIOPHARMACEUTICAL RESEARCH, 2020, 12 (03): : 334 - 343
  • [2] Hierarchical Generalized Linear Models for Multiregional Clinical Trials
    Park, Junhui
    Kang, Seung-Ho
    [J]. STATISTICS IN BIOPHARMACEUTICAL RESEARCH, 2022, 14 (03): : 358 - 367
  • [3] Control of Type I Error Rates in Bayesian Sequential Designs
    Shi, Haolun
    Yin, Guosheng
    [J]. BAYESIAN ANALYSIS, 2019, 14 (02): : 399 - 425
  • [4] Control of type I error rates in Bayesian group sequential designs
    Shi, Haolun
    Yin, Guosheng
    [J]. TRIALS, 2017, 18
  • [5] Application of Bayesian hierarchical models for phase I/II clinical trials in oncology
    Yada, Shinjo
    Hamada, Chikuma
    [J]. PHARMACEUTICAL STATISTICS, 2017, 16 (02) : 114 - 121
  • [6] Type I error control in biomarker-stratified clinical trials
    Parashar, Deepak
    Bowden, Jack
    Starr, Colin
    Wernisch, Lorenz
    Mander, Adrian
    [J]. TRIALS, 2015, 16
  • [7] Type I error control in biomarker-stratified clinical trials
    Deepak Parashar
    Jack Bowden
    Colin Starr
    Lorenz Wernisch
    Adrian Mander
    [J]. Trials, 16
  • [8] A Randomization Method to Control the Type I Error Rates in Best Subset Regression
    Shehata, Yasser A.
    White, Paul
    [J]. JOURNAL OF MODERN APPLIED STATISTICAL METHODS, 2008, 7 (02) : 398 - 407
  • [9] On the Conditional and Unconditional Type I Error Rates and Power of Tests in Linear Models with Heteroscedastic Errors
    Rosopa, Patrick
    Brawley, Alice M.
    Atkinson, Theresa P.
    Robertson, Stephen
    [J]. JOURNAL OF MODERN APPLIED STATISTICAL METHODS, 2018, 17 (02)
  • [10] Modified Goldilocks Design with strict type I error control in confirmatory clinical trials
    Zhan Tianyu
    Zhang Hongtao
    Hartford, Alan
    Mukhopadhyay, Saurabh
    [J]. JOURNAL OF BIOPHARMACEUTICAL STATISTICS, 2020, 30 (05) : 821 - 833